

Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. The company is also involved in the provision of contract manufacturing and orthocare services. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company offers automated instruments and assays, reagents, and other consumables that are used by these instruments to generate test results. Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. Ortho Clinical Diagnostics (Nasdaq: OCDX) is one of the world’s largest pure-play in vitro diagnostics (IVD) companies dedicated to transforming patient care. 7 Health Care Stocks to Buy Even if the Economy Gets Sick.7 Small-Cap Stocks that Present Long-Term Growth Opportunities.7 Transportation Stocks That Can Keep Your Portfolio Moving Forward.7 Retail Stocks That May Still Ring the Register.7 Consumer Discretionary Stocks That May Defy Expectations.7 Outdoor Living Stocks to Buy Before Investors Go Away For the Summer.7 NFT Related Stocks That Are Helping to Drive This Trend.7 Agricultural Technology Stocks to Buy as Commodity Prices Remain Volatile.7 Dividend Stocks to Buy When Safety is Your Top Priority.7 Stagflation Stocks to Help Navigate Periods of Low Growth.7 Commodities ETFs to Help Build a Hedge Against Inflation.


The firms Clinical Labs segment revenues were down 5 percent year over year, though its Transfusion.
ORTHO CLINICAL DIAGNOSTICS SERIES
To ascertain the true anti-HCV status of samples deemed low-positive by the Ortho-Clinical Vitros ECi test, we tested samples using the ADVIA Centaur HCV screen test (Siemens Medical Solutions Diagnostics), the Chiron recombinant immunoblot assay (RIBA) test (Chiron Corp., Emeryville, CA), and the Roche COBAS Amplicor HCV qualitative test (Roche Diagnostics, Indianapolis, IN) in a series of studies. Food and Drug Administration (FDA)-approved confirmatory methodologies.

After observing a high incidence of low positive hepatitis C virus (HCV) antibody screens by the Ortho-Clinical Vitros ECi test (Orthoclinical Diagnostics, Raritan, NJ), we compared results against those obtained using another chemiluminescent analyzer, as well as two U.S.
